{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:36Z","timestamp":1793301156769,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00787-026-03142-z","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:07:18Z","timestamp":1785323238000},"page":"3677-3681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["VigiBase suggests that the number of deaths by suicide in adolescents with schizophrenia as a result of not taking clozapine may be much higher than the number of deaths from agranulocytosis after taking clozapine"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-2413","authenticated-orcid":false,"given":"Sara","family":"Jim\u00e9nez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5742-905X","authenticated-orcid":false,"given":"Carlos","family":"De Las Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6788-4435","authenticated-orcid":false,"given":"Emilio J.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0541-4846","authenticated-orcid":false,"given":"Carmen","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3382-4754","authenticated-orcid":false,"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2314","authenticated-orcid":false,"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"3142_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/JCP.0000000000001990","volume":"45","author":"J de Leon","year":"2025","unstructured":"de Leon J, Baldessarini RJ, Balon R et al (2025) Letter to the FDA proposing major changes in the US clozapine package insert supported by clozapine experts worldwide. Part II: a review of fatal outcomes in US pharmacovigilance data and proposed changes. J Clin Psychopharmacol 45:197\u2013218. https:\/\/doi.org\/10.1097\/JCP.0000000000001990","journal-title":"J Clin Psychopharmacol"},{"key":"3142_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/JCP.0000000000002111","volume":"46","author":"J de Leon","year":"2026","unstructured":"de Leon J, de Leon VC, Sanz EJ, De Las Cuevas C (2026) Clozapine and suicide in VigiBase: most important fatal outcome in young males and differences between attempted and completed suicide. J Clin Psychopharmacol 46:5\u201315. https:\/\/doi.org\/10.1097\/JCP.0000000000002111","journal-title":"J Clin Psychopharmacol"},{"key":"3142_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2026.0086","author":"X Li","year":"2026","unstructured":"Li X, Lu C, Zhai Z, Smith RC, Zhang S, Wang H et al (2026) Clozapine after 1 failed antipsychotic drug trial in first-episode psychosis: a randomized clinical trial. JAMA Psychiatry. https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.0086","journal-title":"JAMA Psychiatry"},{"key":"3142_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2215-0366(24)00366-3","volume":"12","author":"H Taipale","year":"2025","unstructured":"Taipale H, Tanskanen A, Howes O et al (2025) Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study. Lancet Psychiatry 12:122\u2013130. https:\/\/doi.org\/10.1016\/S2215-0366(24)00366-3","journal-title":"Lancet Psychiatry"},{"key":"3142_CR5","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00787-024-02623-3","volume":"34","author":"C De Las Cuevas","year":"2025","unstructured":"De Las Cuevas C, Sanz EJ, Jim\u00e9nez-Fern\u00e1ndez S, Schoretsanitis G, Ruan CJ, de Leon J (2025) Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data. Eur Child Adolesc Psychiatry 34:2083\u20132091. https:\/\/doi.org\/10.1007\/s00787-024-02623-3","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3142_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll CU, Solmi M, Croatto G et al (2022) Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry 21:248\u2013271. https:\/\/doi.org\/10.1002\/wps.20994","journal-title":"World Psychiatry"},{"key":"3142_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/archpsyc.62.3.247","volume":"62","author":"BA Palmer","year":"2005","unstructured":"Palmer BA, Pankratz VS, Bostwick JM (2005) The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 62:247\u2013253. https:\/\/doi.org\/10.1001\/archpsyc.62.3.247","journal-title":"Arch Gen Psychiatry"},{"key":"3142_CR8","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.2444","volume":"68","author":"SH Ang","year":"2025","unstructured":"Ang SH, Venkateswaran S, Goda MB, Naidu KNC, Kundadak GK, Subramaniam M (2025) Prevalence of suicidal behaviour in adolescents and youth at ultra-high risk for psychosis: a systematic review and meta-analysis. Eur Psychiatry 68:e56. https:\/\/doi.org\/10.1192\/j.eurpsy.2025.2444","journal-title":"Eur Psychiatry"},{"key":"3142_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1080\/14740338.2024.2399094","volume":"24","author":"C De Las Cuevas","year":"2025","unstructured":"De Las Cuevas C, de Leon VC, Blasco-Fontecilla H et al (2025) Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature. Expert Opin Drug Saf 24:1301\u20131311. https:\/\/doi.org\/10.1080\/14740338.2024.2399094","journal-title":"Expert Opin Drug Saf"},{"key":"3142_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2025.112747","volume":"104","author":"J de Leon","year":"2026","unstructured":"de Leon J (2026) Prescribing clozapine to 10% of patients with schizophrenia may save 320,000 lives and cost 2400 deaths from agranulocytosis. Eur Neuropsychopharmacol 104:112747. https:\/\/doi.org\/10.1016\/j.euroneuro.2025.112747","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03142-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03142-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03142-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:23:48Z","timestamp":1792988628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03142-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3142"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03142-z","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study followed the principles of the Declaration of Helsinki and adhered to stringent data anonymization protocols which eliminated the need for ethics committee approval at the university of the authors who downloaded the files.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the last 3 years, (1) CA has been a consultant to or has received honoraria or grants from Abbott, Acadia, Ambrosetti, Angelini, Biogen, BMS, Boehringer, Carnot, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Rovi, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, Takeda and Teva: (2) CM has been a consultant to or has received honoraria from Angelini, Janssen, Lundbeck, Otsuka, Rovi, Servier, Sunovion and Teva outside the submitted work; and (3) the other authors report no conflict of interest.\u00a0CM is an editorial board member for this journal and also a listed author of this article.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}